U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C2H2O4
Molecular Weight 90.035
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of OXALIC ACID

SMILES

C(=O)(C(=O)O)O

InChI

InChIKey=MUBZPKHOEPUJKR-UHFFFAOYSA-N
InChI=1S/C2H2O4/c3-1(4)2(5)6/h(H,3,4)(H,5,6)

HIDE SMILES / InChI

Molecular Formula C2H2O4
Molecular Weight 90.035
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Automatic segmentation of medical images for renal calculi and analysis.
2001
A common carbanion intermediate in the recombination and proton-catalysed disproportionation of the carboxyl radical anion, CO2*-, in aqueous solution.
2001
The DNA-repair protein AlkB, EGL-9, and leprecan define new families of 2-oxoglutarate- and iron-dependent dioxygenases.
2001
Diplazium sammatii: Athyraceae ('Nyama idim'): age-related nutritional and antinutritional analysis.
2001
Urine volume and its effects on renal stone risk in astronauts.
2001 Apr
Does exhaustive search for microcalcifications improve diagnostic yield in stereotactic core needle breast biopsies?
2001 Apr
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats.
2001 Apr
Early stage of urolithiasis formation in experimental hyperparathyroidism.
2001 Apr
Sulfate and chloride transport in Caco-2 cells: differential regulation by thyroxine and the possible role of DRA gene.
2001 Apr
The solubility of calcium oxalate in tissue culture media.
2001 Apr 1
Mechanisms of wood degradation by brown-rot fungi: chelator-mediated cellulose degradation and binding of iron by cellulose.
2001 Apr 27
Morphology and anatomy of developing fruits and seeds of Vismia guianensis (Aubl.) Choisy (Clusiaceae).
2001 Feb
Effects of citrate on renal stone formation and osteopontin expression in a rat urolithiasis model.
2001 Feb
The relation of urinary Tamm-Horsfall-protein on CaOx-crystallization under the scope of the Bonn-Risk-Index.
2001 Feb
Renal tubular injury induced by hyperoxaluria: evaluation of apoptotic changes.
2001 Feb
Modelling of auxin-binding protein 1 suggests that its C-terminus and auxin could compete for a binding site that incorporates a metal ion and tryptophan residue 44.
2001 Feb
CT and stone fragility.
2001 Feb
Ultrastructure of selected calcium oxalate-containing urinary calculi from dogs.
2001 Feb
Complex effects of papain on function and inhibitor sensitivity of the red cell anion exchanger AE1 suggest the presence of different transport subsites.
2001 Feb 1
Syntheses, crystal structures, and magnetic properties of the oxalato-bridged mixed-valence complexes (FeII(bpm)3]2[FeIII2(ox)5].8H2O and FeII(bpm)3Na(H2O)2Fe(ox)(3).4H2O (bpm = 2,2'-bipyrimidine).
2001 Feb 12
Calcium oxalate microdeposition in failing kidney grafts.
2001 Feb-Mar
[Photooxidation of acridine orange in homogeneous system containing Fe3+ and H2O2 under visible irradiation].
2001 Jan
Arsenic characterisation in industrial soils by chemical extractions.
2001 Jan
Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.
2001 Jan
Improvement of a standard MIRA method for urinary oxalate by elimination of reagent carry-over.
2001 Jan
Effect of potential renal acid load of foods on calcium metabolism of renal calcium stone formers.
2001 Jan
Supramolecular squares with Mo2(4+) corners.
2001 Jan 29
Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease.
2001 Jan-Feb
[Isolation and characterization of polysaccharides from Tansy].
2001 Jan-Feb
Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
2001 Jun
Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone formers.
2001 Jun
Cystine calculi in children: the results of a metabolic evaluation and response to medical therapy.
2001 Jun
Two-dimensional coordination polymers of copper(II) with oxalate: lattice water control of structure.
2001 Jun 4
Hippuric acid as a modifier of calcium oxalate crystallisation.
2001 Mar
Synthesis and muscarinic activity of 1,2,3,4-tetrahydropyrimidine derivatives.
2001 Mar
Mediaeval cantorals in the Valladolid Biblioteca: FT-Raman spectroscopic study.
2001 Mar
Diets with either beef or plant proteins reduce risk of calcium oxalate precipitation in patients with a history of calcium kidney stones.
2001 Mar
Whewellite, weddellite and company: where do all the strange names originate?
2001 Mar
The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects.
2001 Mar
The simplest supramolecular complexes containing pairs of Mo(2)(formamidinate)(3) units linked with various dicarboxylates: preparative methods, structures, and electrochemistry.
2001 Mar 12
Simultaneous measurement of dopamine and ascorbate at their physiological levels using voltammetric microprobe based on overoxidized poly(1,2-phenylenediamine)-coated carbon fiber.
2001 Mar 15
Effect of several organic acids on phosphate adsorption by variable charge soils of central China.
2001 May
A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels.
2001 May
A critical appraisal of the hypothesis that urine is a saturated equilibrium with respect to stone-forming calcium salts.
2001 May
Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
2001 May
[Study of renal function in infants diagnosed with renal pyelectasis in the first year of life].
2001 May
Oxidation of lignin in eucalyptus kraft pulp by manganese peroxidase from Bjerkandera sp. strain BOS55.
2001 May
Simple, sensitive and accurate method for the quantification of prothrombin mRNA by using competitive PCR.
2001 May 15
Patents
Substance Class Chemical
Created
by admin
on Sat Jun 26 07:51:56 UTC 2021
Edited
by admin
on Sat Jun 26 07:51:56 UTC 2021
Record UNII
9E7R5L6H31
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OXALIC ACID
HSDB   INCI   MI   VANDF   WHO-DD  
INCI  
Official Name English
OXALIPLATIN RELATED COMPOUND A [USP]
Common Name English
OXALIC ACID [HSDB]
Common Name English
OXALIC ACID [WHO-DD]
Common Name English
OXALIPLATIN IMPURITY A [EP]
Common Name English
ETHANEDIOIC ACID
Systematic Name English
NSC-62774
Code English
OXALIC ACID [VANDF]
Common Name English
OXALIPLATIN RELATED COMPOUND A [USP-RS]
Common Name English
OXALIC ACID [MI]
Common Name English
OXALIPLATIN RELATED COMPOUND A
USP  
Common Name English
OXALIC ACID [INCI]
Common Name English
Classification Tree Code System Code
LOINC 13483-3
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 20927-0
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
EPA PESTICIDE CODE 9601
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 34350-9
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 2699-7
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 2700-3
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 47715-8
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 27222-9
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 14861-9
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 57375-8
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 20928-8
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 57373-3
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 15085-4
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 26796-3
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 15086-2
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 57374-1
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 34349-1
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 49937-6
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 55961-7
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
WHO-VATC QP53AG03
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 14862-7
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 13788-5
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
LOINC 2701-1
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
Code System Code Type Description
EVMPD
SUB32959
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
DRUG BANK
DB03902
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
MERCK INDEX
M8280
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY Merck Index
USP_CATALOG
1481215
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY USP-RS
FDA UNII
9E7R5L6H31
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
RXCUI
1427058
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY RxNorm
PUBCHEM
971
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
NCI_THESAURUS
C84036
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
ECHA (EC/EINECS)
205-634-3
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
MESH
D019815
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
WIKIPEDIA
OXALIC ACID
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
RXCUI
1441660
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
NCI_THESAURUS
C45678
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
CONCEPT Industrial Aid
EPA CompTox
144-62-7
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
CAS
144-62-7
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
HSDB
1100
Created by admin on Sat Jun 26 07:51:58 UTC 2021 , Edited by admin on Sat Jun 26 07:51:58 UTC 2021
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
METABOLIC ENZYME -> SUBSTRATE
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
Related Record Type Details
PARENT -> IMPURITY
ASSAY (COLORIMETRIC)
USP
PARENT -> IMPURITY
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
PARENT -> IMPURITY
Related Record Type Details
ACTIVE MOIETY